Obesity, sex, and acetaminophen disposition

Area of Science:

• Pharmacokinetics
• Obesity Research
• Drug Metabolism

Background:

• Understanding how obesity affects drug pharmacokinetics is crucial for safe and effective medication use.
• Acetaminophen is a widely used analgesic, and its behavior in obese individuals requires investigation.

Purpose of the Study:

• To investigate the impact of obesity and sex on the pharmacokinetics of acetaminophen.
• To determine if acetaminophen dosing needs adjustment in obese individuals.

Main Methods:

• Single intravenous dose of acetaminophen (650 mg) administered to obese and normal-weight men and women.
• Measured pharmacokinetic parameters including elimination half-life, volume of distribution (Vd), and metabolic clearance.
• Analyzed Vd and clearance corrected for total body weight (TBW) and ideal body weight (IBW).

Main Results:

• Absolute Vd and clearance of acetaminophen were significantly higher in obese individuals and men compared to their normal-weight counterparts and women, respectively.
• However, Vd and clearance corrected for TBW were lower in obese subjects than in normal-weight subjects of the same sex.
• Acetaminophen clearance increased with body weight, being greater in obese patients and men.

Conclusions:

• Acetaminophen's volume of distribution increases with obesity and male sex, but its distribution into excess body weight is less extensive than into ideal body weight.
• Acetaminophen clearance is significantly influenced by body weight, increasing in obese individuals and men.
• The findings suggest that while absolute Vd and clearance are higher in obese individuals, weight-adjusted parameters indicate that standard dosing may be appropriate, warranting further clinical validation.